Suppression of neointimal hyperplasia after vascular injury by blocking 4-1BB/4-1BB ligand pathway

Journal of Medical and Dental Sciences

Volumn 55, Issue 2, 2008, Pages 207-213

  Karube, Akiyo ^a   Suzuki, Jun Ichi ^a   Haraguchi, Go ^a   Maejima, Yasuhiro ^a   Saiki, Hitoshi ^a   Kosuge, Hisanori ^a   Isobe, Mitsuaki ^a   Uede, Toshimitsu ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

4 1 BB; Inflammation; Smooth muscle cells; Vascular injury

Indexed keywords

ACTIN; CD137 ANTIGEN; CD137 LIGAND; DIAGNOSTIC AGENT; IMMUNOGLOBULIN G;

ANIMAL; ARTERIOSCLEROSIS; ARTICLE; C57BL MOUSE; CONFOCAL MICROSCOPY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; FEMORAL ARTERY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; HYPERPLASIA; INJURY; INTIMA; MALE; MOUSE; MOUSE STRAIN; PATHOLOGY; SMOOTH MUSCLE FIBER; TUNICA MEDIA; VASCULAR SMOOTH MUSCLE;

4-1BB LIGAND; ACTINS; ANIMALS; ANTIGENS, CD137; ARTERIOSCLEROSIS; DISEASE MODELS, ANIMAL; FEMORAL ARTERY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; HYPERPLASIA; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICROSCOPY, CONFOCAL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; TUNICA INTIMA; TUNICA MEDIA;

EID: 52449123995     PISSN: 13428810     EISSN: 13428810     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Farb A, Weber DK, Kolodgie FD, et al. Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002; 105: 2974-80.
2. Costa MA, Simon Dl. Molecular basis of restenosis and drug-eluting stents. Circulation 2005;111:2257-73.
3. Luscher TF, Steffel J, Eberli FR, et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 2007;115:1051-8.
4. Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002;22:1769-76.
5. Isobe M, Kosuge H, Suzuki J. T cell costimulation in the development of cardiac allograft vasculopathy: potential targets for therapeutic interventions. Arterioscler Thromb Vasc Biol 2006;26:1447-56.
6. Watts TH. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005;23:23-68.
7. Cho HR, Kwon B, Yagita H, et al. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival. Transpl Int 2004;17:351-61.
8. Huang BJ, Yin H, Huang YF, et al. Gene therapy using adenoviral vector encoding 4-1BBIg gene significantly prolonged murine cardiac allograft survival. Transpl Immunol 2006;16:88-94.
9. Sun Y, Lin X, Chen HM, et al. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. J Immunol 2002;168:1457-65.
10. Kosuge H, Suzuki J, Gotoh R, et al. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway. Transplantation 2003;75:1374-9.
11. Kosuge H, Suzuki J, Kakuta T, et al. Attenuation of graft arterial disease by manipulation of the LIGHT pathway. Arterioscler Thromb Vasc Biol 2004;24:1409-15.
12. Sata M, Maejima Y, Adachi F, et al. A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol 2000;32:2097-104.
13. Gotoh R, Suzuki J, Kosuge H, et al. E-selectin blockade decreases adventitial inflammation and attenuates intimal hyperplasia in rat carotid arteries after balloon injury. Arterioscler Thromb Vasc Biol 2004;24:2063-8.
14. Saoulli K, Lee SY, Cannons JL, et al. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J Exp Med 1998;187:1849-62.
15. Vinay DS, Kwon BS. Role of 4-1 BB in immune responses. Semin Immunol 1998;10:481-9.
16. DeFina R, Christopher K, He H, et al. Analysis of costimulation by 4-1BBL, CD40L, and B7 in graft rejection by gene expression profiles. J Mol Med 2003;81:655-63.
17. Seo SK, Choi JH, Kim YH, et al. 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat Med 2004;10:1088-94.
18. Foell J, Strahotin S, O'Neil SR et al. CD137 costimulatory T cell receptor engagement reverses acute disease in lupusprone NZB × NZW F1 mice. J Clin Invest 2003;111:1505-18.
19. Melero I, Shuford WW, Newby SA, et al. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med 1997;3:682-5.
20. Seko Y, Sugishita K, Sato O, et al. Expression of costimulatory molecules (4-1BBL and Fas) and major histocompatibility class I chain-related A (MICA) in aortic tissue with Takayasu's arteritis. J Vasc Res 2004;41:84-90.
21. Saiki H, Suzuki J, Kosuge H, et al. Blockade of the 4-1BB pathway attenuates graft arterial disease in cardiac allografts. Int Heart J 2008;49:105-118.
22. Koga N, Suzuki J, Kosuge H, et al. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts. Arterioscler Thromb Vasc Biol 2004;24:2057-62.
23. Kosuge H, Suzuki J, Haraguchi G, et al. Critical role of inducible costimulator signaling in the development of arteriosclerosis. Arterioscler Thromb Vasc Biol 2006;26:2660-5.
24. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006;86:515-81.